📊 GRAL Key Takeaways
Is GRAL a Good Investment? Thesis Analysis
GRAL shows encouraging revenue growth (+17.2% YoY) and improving losses (net income +79.9% YoY), but faces critical cash runway concerns with $299M annual operating burn against only $249.7M cash reserves, leaving approximately 10 months of liquidity. Despite a strong balance sheet, the company must achieve profitability or secure additional capital immediately.
GRAIL shows modest revenue growth but remains far from profitability, with extremely negative operating and free cash flow margins and a large operating loss. A strong, debt‑free balance sheet and ample liquidity provide runway, yet current burn suggests a need for material scaling and cost improvements to reach breakeven. Without clear evidence of improving unit economics, the risk of future funding needs or dilution remains elevated.
Why Buy GRAL? Key Strengths
- Solid revenue growth at 17.2% YoY indicates market traction
- Net losses improving significantly (79.9% YoY improvement suggests operational progress)
- Fortress balance sheet with $2.6B equity, minimal debt, and strong liquidity ratios (11.97x current ratio)
- Debt-free balance sheet with high liquidity (11.97x current ratio)
- Improving net loss and EPS on a year-over-year basis
- Low capital intensity (minimal capex) enabling focus on operating leverage
GRAL Investment Risks to Consider
- Unsustainable operating cash burn of $299M annually against $249.7M cash reserves creates critical 10-month runway
- Severely unprofitable with -277.5% net margin and -382% operating margin with no near-term profitability visible
- Company requires either rapid profitability achievement or capital raise to avoid insolvency within 12 months
- Severe cash burn and negative FCF margin (-203.8%)
- Extremely negative operating margin (-382%) indicating weak unit economics
- Potential dilution or funding needs if growth and margins do not improve
Key Metrics to Watch
- Operating cash flow trend and rate of burn reduction quarterly
- Gross margin realization and path to positive unit economics
- Capital raise announcements or strategic financing events to extend runway
- Operating cash flow (burn and runway)
- Revenue growth and operating margin improvement
GRAL Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 11.97x current ratio provides a solid financial cushion.
GRAL Profitability Ratios
GRAL vs Healthcare Sector
How GRAIL, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is GRAL Overvalued or Undervalued?
Based on fundamental analysis, GRAIL, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
GRAL Balance Sheet & Liquidity
GRAL 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: GRAIL, Inc.'s revenue has grown significantly by 17% over the 5-year period, indicating strong business expansion. The most recent EPS of $-47.21 indicates the company is currently unprofitable.
GRAL Growth Metrics (YoY)
GRAL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $28.7M | -$89.0M | $-2.46 |
| Q2 2025 | $32.0M | -$106.2M | $-3.18 |
| Q1 2025 | $26.7M | -$106.2M | $-3.10 |
| Q3 2024 | $20.7M | -$125.7M | $-3.94 |
| Q2 2024 | $22.4M | -$193.0M | $-6.22 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
GRAL Capital Allocation
GRAL SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for GRAIL, Inc. (CIK: 0001699031)
📋 Recent SEC Filings
❓ Frequently Asked Questions about GRAL
What is the AI rating for GRAL?
GRAIL, Inc. (GRAL) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 76% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are GRAL's key strengths?
Claude: Solid revenue growth at 17.2% YoY indicates market traction. Net losses improving significantly (79.9% YoY improvement suggests operational progress). ChatGPT: Debt-free balance sheet with high liquidity (11.97x current ratio). Improving net loss and EPS on a year-over-year basis.
What are the risks of investing in GRAL?
Claude: Unsustainable operating cash burn of $299M annually against $249.7M cash reserves creates critical 10-month runway. Severely unprofitable with -277.5% net margin and -382% operating margin with no near-term profitability visible. ChatGPT: Severe cash burn and negative FCF margin (-203.8%). Extremely negative operating margin (-382%) indicating weak unit economics.
What is GRAL's revenue and growth?
GRAIL, Inc. reported revenue of $147.2M.
Does GRAL pay dividends?
GRAIL, Inc. does not currently pay dividends.
Where can I find GRAL SEC filings?
Official SEC filings for GRAIL, Inc. (CIK: 0001699031) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is GRAL's EPS?
GRAIL, Inc. has a diluted EPS of $-11.11.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is GRAL a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, GRAIL, Inc. has a SELL rating with 76% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is GRAL stock overvalued or undervalued?
Valuation metrics for GRAL: ROE of -15.8% (sector avg: 15%), net margin of -277.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy GRAL stock in 2026?
Our dual AI analysis gives GRAIL, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is GRAL's free cash flow?
GRAIL, Inc.'s operating cash flow is $-299.0M, with capital expenditures of $909.0K. FCF margin is -203.8%.
How does GRAL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -277.5% (avg: 12%), ROE -15.8% (avg: 15%), current ratio 11.97 (avg: 2).